期刊文献+

埃索美拉唑、克拉霉素与甲硝唑联合治疗消化性溃疡65例 被引量:7

Clinical observation on triple therapy for 65 cases of peptic ulcer with esomeprazole,clarithromycin and metronidazole
下载PDF
导出
摘要 目的研究埃索美拉唑、克拉霉素、甲硝唑三联治疗消化性溃疡的疗效。方法将126例经内镜诊断并检测证实幽门螺杆菌(Hp)阳性的消化性溃疡患者随机分为两组。治疗组65例,给予埃索美拉唑20mg+克拉霉素500mg+甲硝唑400mg,每日2次,共7d;对照组61例,给予奥美拉唑20mg+克拉霉素500mg+甲硝唑400mg,每日2次,共7d。疗程结束4周后复查胃镜并检测Hp,观察腹痛缓解率、溃疡愈合率,Hp根除率及用药后的不良反应等。结果治疗组组第1d和第2d腹痛缓解率分别为33.8%和53.8%,高于对照组的16.4%和39.3%,有显著性差异(P<0.05)。治疗组和对照组溃疡治愈率分别为90.8%和86.9%,治疗组和对照组Hp根除率分别为90.8%和86.9%,差异无显著性(P>0.05)。两组用药后不良反应少,有较好的安全性。结论埃索美拉唑、克拉霉素、甲硝唑三联疗法治疗Hp阳性的消化性溃疡安全有效,腹痛缓解速度优于奥美拉唑三联疗法。 Objective To investigate the effect of esomeprazole,clarithromycin and metronidazole triple therapy for helicobactor pylori(Hp) infection in peptic ulcer patients. Methods 126 cases with peptic ulcer and Hp infection were divided into two groups. Treatment group (65 cases) treated with esomeprazole ( 20 mg), clarithromycin ( 500 mg) and metronidazole ( 400 mg) twice daily, and control group ( 61 cases) treated with omeprazole( 20 mg) , clarithromycin (500 mg) and metronidazole (400 mg)twice daily . The treatment lasted for 7days. After which abdominal pain relief rate, ulcer healing rate and eradication rate of Hp as well as effects of the medication were evaluated and compared. Results On the first and the second days of medication , the abdominal pain relief rates were 33.8% and 53.8% respectively in treatment group ,significantly higher than those in control group (16.4% and 39.3% ). There were significant differences between the two groups respectively( P 〈0.05 ). Ulcer healing rate were 90.8% and 86.9% in treatment group and control group ,and eradication rate of Hp were 90.8% and 86.9% in treatment group and control group. There were no significant differences between the two groups( P 〉 0.05 ). The adverse effects of the medication were rare in both groups without significant differences. Conclusion Esomeprazole,clarithromycin and metronidazole triple therapy may effectively eradicate Hp infection and promote petic ulcer healing with good tolerance ,capable of achieving more speedy pain relief than omeprazole -based therapy.
出处 《临床和实验医学杂志》 2008年第5期46-47,共2页 Journal of Clinical and Experimental Medicine
关键词 埃索美拉唑 克拉霉素 甲硝唑 奥美拉唑 消化性溃疡 Esomeprazole Clarithromycin Metronidazole Omeprazole Peptic ulcer
  • 相关文献

参考文献9

二级参考文献24

  • 1袁楚明,陈健芳,吴小珑.耐信治疗难治性溃疡45例临床观察[J].基层医学论坛,2005,9(8):710-711. 被引量:5
  • 2Andersson T, RohsK, Hassan-Alin M, et al. Pharmacokinetics(PK) and does-response relationship of esomeprazole [ J ]. Gastroenterology, 2000,118 : A5550.
  • 3Zsolt T, Puldrzej K, Petr Dite, et al. One week esomeprazole-based triple therapy eradicatication Helicobacter pylori and heals patients with duodenal ulcer disease [J]. Eur J Gastroenterol Hepatol,2001,13(12) : 1457 - 1465.
  • 4Thitiphuree S, Talley NJ. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy [J]. Int J Clin Praet, 2000, 54(8): 537-41.
  • 5Rohss K, Hasselgren G, Hedenstrom H. Effect of esomeprazole 40mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease [J]. Dig Dis Sci, 2002,47: 954-8.
  • 6Laine L, Fenneety MB, Osto M, et al. Esomeprazeole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials [J].Am J Gastroenterol, 2000, 95(12): 3393-8.
  • 7Malfertheiner P, Megraud F, O'Morain C, et al. European Helicobacter Pylori Study Group(EHPSG). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther, 2002,16:167-180.
  • 8赵景涛 刘玉兰.消化内科学[M].北京:中国协和医科大学出版社,2000..
  • 9张家铨,吴景时,程鹏主编.常用药物手册[M].北京:人民卫生出版社,2000:796
  • 10中华医学会消化病学分会.幽门螺杆菌若干问题的共识意见.中华消化杂志,2004,24(2):126-127.

共引文献618

同被引文献45

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部